J. Christopher Glantz
Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Pregnancy Outcome | 12 | 1994 | 54 |
Why?
| Labor, Induced | 8 | 1997 | 10 |
Why?
| Cesarean Section | 9 | 1997 | 41 |
Why?
| Pregnancy | 39 | 1991 | 455 |
Why?
| Parity | 6 | 1997 | 28 |
Why?
| Hospitals, Maternity | 2 | 2004 | 3 |
Why?
| Ultrasonography, Prenatal | 7 | 1994 | 41 |
Why?
| Delivery, Obstetric | 3 | 1997 | 21 |
Why?
| Pregnancy Complications | 6 | 1991 | 98 |
Why?
| Pregnancy Complications, Infectious | 4 | 1994 | 35 |
Why?
| Female | 46 | 1991 | 1643 |
Why?
| Infant, Newborn | 12 | 1993 | 389 |
Why?
| Anesthesia, Local | 2 | 2001 | 17 |
Why?
| Vaginal Diseases | 2 | 2005 | 16 |
Why?
| Premature Birth | 2 | 2006 | 21 |
Why?
| Retrospective Studies | 13 | 2003 | 653 |
Why?
| Obstetrics and Gynecology Department, Hospital | 2 | 1999 | 9 |
Why?
| Fetal Monitoring | 1 | 2011 | 8 |
Why?
| Adult | 26 | 1993 | 1317 |
Why?
| Fetal Heart | 1 | 2011 | 13 |
Why?
| Pre-Eclampsia | 2 | 2006 | 18 |
Why?
| Uterine Hemorrhage | 1 | 2010 | 17 |
Why?
| Infant, Newborn, Diseases | 1 | 2010 | 33 |
Why?
| Humans | 45 | 1991 | 1856 |
Why?
| Hydatidiform Mole | 3 | 1993 | 8 |
Why?
| Cocaine | 3 | 1993 | 33 |
Why?
| Proteinuria | 1 | 2008 | 20 |
Why?
| Gestational Age | 7 | 1993 | 114 |
Why?
| Obesity | 3 | 2003 | 149 |
Why?
| Fetal Diseases | 4 | 1993 | 39 |
Why?
| Creatinine | 1 | 2008 | 69 |
Why?
| Tocolytic Agents | 1 | 2007 | 6 |
Why?
| Leukomalacia, Periventricular | 1 | 2007 | 7 |
Why?
| Enterocolitis, Necrotizing | 1 | 2007 | 9 |
Why?
| Indomethacin | 1 | 2007 | 43 |
Why?
| Odds Ratio | 5 | 1996 | 157 |
Why?
| Nucleoside-Diphosphate Kinase | 1 | 2006 | 4 |
Why?
| Antigens, CD44 | 1 | 2006 | 18 |
Why?
| Cadherins | 1 | 2006 | 32 |
Why?
| Vagina | 1 | 2005 | 30 |
Why?
| Uterine Neoplasms | 1 | 2006 | 52 |
Why?
| Conscious Sedation | 1 | 2005 | 26 |
Why?
| Mass Screening | 2 | 1997 | 125 |
Why?
| Progesterone | 2 | 1994 | 42 |
Why?
| Diagnosis-Related Groups | 1 | 2004 | 21 |
Why?
| Streptococcus agalactiae | 2 | 1998 | 12 |
Why?
| Obstetric Labor Complications | 1 | 2003 | 15 |
Why?
| Maternal Health Services | 1 | 2003 | 11 |
Why?
| Vaginosis, Bacterial | 2 | 1997 | 5 |
Why?
| Pregnancy Trimester, Second | 4 | 1994 | 25 |
Why?
| Risk Factors | 7 | 1994 | 555 |
Why?
| Meconium Aspiration Syndrome | 1 | 2002 | 3 |
Why?
| Neonatology | 1 | 2002 | 4 |
Why?
| Ethics | 1 | 2002 | 7 |
Why?
| Research Design | 2 | 1997 | 169 |
Why?
| New York | 7 | 1995 | 422 |
Why?
| Length of Stay | 3 | 2005 | 166 |
Why?
| Streptococcal Infections | 2 | 1998 | 54 |
Why?
| Oligohydramnios | 1 | 2001 | 4 |
Why?
| Heart Rate, Fetal | 1 | 2001 | 10 |
Why?
| Procaine | 1 | 2001 | 7 |
Why?
| Abortion, Therapeutic | 1 | 2001 | 7 |
Why?
| Apgar Score | 2 | 2010 | 15 |
Why?
| Intensive Care Units, Neonatal | 2 | 2010 | 33 |
Why?
| Substance-Related Disorders | 2 | 1991 | 96 |
Why?
| Risk Adjustment | 1 | 1999 | 16 |
Why?
| Logistic Models | 6 | 1994 | 251 |
Why?
| Chromosome Aberrations | 1 | 1999 | 45 |
Why?
| Analgesia, Epidural | 2 | 2007 | 16 |
Why?
| Echocardiography | 1 | 1999 | 93 |
Why?
| Chickenpox | 1 | 1998 | 20 |
Why?
| Heart | 1 | 1999 | 88 |
Why?
| Dystocia | 1 | 1997 | 3 |
Why?
| Infant, Premature | 2 | 2007 | 70 |
Why?
| Decision Support Techniques | 1 | 1998 | 43 |
Why?
| Birth Weight | 2 | 2006 | 50 |
Why?
| Models, Theoretical | 1 | 1997 | 124 |
Why?
| Obstetric Labor, Premature | 2 | 1997 | 17 |
Why?
| Amnion | 1 | 1996 | 13 |
Why?
| Infusion Pumps | 1 | 1996 | 18 |
Why?
| Papillary Muscles | 1 | 1995 | 14 |
Why?
| Birth Certificates | 2 | 2004 | 4 |
Why?
| Alkylating Agents | 1 | 1994 | 15 |
Why?
| Polyhydramnios | 1 | 1994 | 4 |
Why?
| Reproduction | 1 | 1994 | 21 |
Why?
| Pregnancy, Animal | 1 | 1994 | 20 |
Why?
| Pregnancy Complications, Hematologic | 1 | 1994 | 16 |
Why?
| Cardiovascular System | 1 | 1994 | 40 |
Why?
| Urinary Incontinence | 2 | 2002 | 28 |
Why?
| Mitral Valve Stenosis | 1 | 1993 | 13 |
Why?
| Phencyclidine | 1 | 1993 | 5 |
Why?
| Endometrial Neoplasms | 2 | 2003 | 18 |
Why?
| Heroin Dependence | 1 | 1993 | 8 |
Why?
| Thrombocytopenia | 1 | 1994 | 46 |
Why?
| Autoimmune Diseases | 1 | 1994 | 49 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 1993 | 28 |
Why?
| Sensitivity and Specificity | 5 | 1998 | 427 |
Why?
| Probability | 3 | 2001 | 190 |
Why?
| Balloon Dilation | 1 | 1993 | 42 |
Why?
| Adolescent | 5 | 1993 | 891 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2011 | 4 |
Why?
| Acceleration | 1 | 2011 | 13 |
Why?
| Prenatal Care | 1 | 1991 | 35 |
Why?
| Postpartum Hemorrhage | 1 | 2011 | 4 |
Why?
| Body Mass Index | 3 | 2003 | 122 |
Why?
| Intensive Care, Neonatal | 1 | 2011 | 12 |
Why?
| Case-Control Studies | 3 | 2006 | 283 |
Why?
| Morbidity | 1 | 2011 | 62 |
Why?
| Laminaria | 1 | 2010 | 5 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 1993 | 46 |
Why?
| alpha-Fetoproteins | 1 | 2010 | 12 |
Why?
| Ascorbic Acid | 1 | 2010 | 37 |
Why?
| Fetal Macrosomia | 2 | 2006 | 6 |
Why?
| Abortion, Induced | 1 | 2010 | 26 |
Why?
| Amniotic Fluid | 1 | 2010 | 25 |
Why?
| Term Birth | 1 | 2010 | 2 |
Why?
| Tricuspid Valve | 1 | 2010 | 16 |
Why?
| Patient Admission | 1 | 2010 | 72 |
Why?
| Mitral Valve | 1 | 2010 | 24 |
Why?
| Databases, Factual | 1 | 2010 | 102 |
Why?
| Down Syndrome | 1 | 2010 | 29 |
Why?
| Young Adult | 2 | 2010 | 380 |
Why?
| Postoperative Complications | 2 | 2003 | 305 |
Why?
| Anti-Bacterial Agents | 2 | 1998 | 195 |
Why?
| Kidney Function Tests | 1 | 2008 | 24 |
Why?
| Anthropometry | 1 | 2008 | 32 |
Why?
| Risk Assessment | 2 | 2010 | 324 |
Why?
| Neoplasm Invasiveness | 2 | 2003 | 105 |
Why?
| Predictive Value of Tests | 2 | 2003 | 321 |
Why?
| Levonorgestrel | 2 | 1995 | 2 |
Why?
| Pregnancy Trimester, First | 2 | 1994 | 23 |
Why?
| Penicillin G | 1 | 2007 | 11 |
Why?
| ROC Curve | 1 | 2008 | 80 |
Why?
| Interleukin-6 | 1 | 2010 | 145 |
Why?
| Cystadenocarcinoma, Papillary | 2 | 2003 | 5 |
Why?
| Adenocarcinoma, Clear Cell | 2 | 2003 | 8 |
Why?
| Oxygen | 1 | 2011 | 179 |
Why?
| Age Factors | 2 | 1994 | 480 |
Why?
| HIV Infections | 1 | 1994 | 136 |
Why?
| Analgesia, Obstetrical | 1 | 2007 | 8 |
Why?
| NM23 Nucleoside Diphosphate Kinases | 1 | 2006 | 5 |
Why?
| Infant, Premature, Diseases | 1 | 2007 | 37 |
Why?
| Cephalopelvic Disproportion | 1 | 2006 | 1 |
Why?
| Infant, Small for Gestational Age | 1 | 2006 | 4 |
Why?
| Cost-Benefit Analysis | 2 | 1997 | 118 |
Why?
| Prospective Studies | 4 | 1994 | 545 |
Why?
| Continental Population Groups | 1 | 2007 | 85 |
Why?
| Colpotomy | 1 | 2005 | 3 |
Why?
| Perineum | 1 | 2005 | 10 |
Why?
| Herniorrhaphy | 1 | 2005 | 12 |
Why?
| Urinary Retention | 1 | 2005 | 13 |
Why?
| Biological Markers | 1 | 2008 | 262 |
Why?
| Blood Loss, Surgical | 1 | 2005 | 28 |
Why?
| Uterine Prolapse | 1 | 2005 | 8 |
Why?
| Anesthesia, Epidural | 1 | 2005 | 11 |
Why?
| Anesthesia, General | 1 | 2005 | 42 |
Why?
| Time Factors | 3 | 2005 | 896 |
Why?
| Patient Discharge | 1 | 2005 | 61 |
Why?
| Cystadenocarcinoma, Serous | 1 | 2004 | 5 |
Why?
| Reconstructive Surgical Procedures | 1 | 2005 | 53 |
Why?
| Prevalence | 2 | 2002 | 281 |
Why?
| Databases as Topic | 1 | 2004 | 27 |
Why?
| Tumor Markers, Biological | 1 | 2006 | 112 |
Why?
| Brachytherapy | 1 | 2004 | 32 |
Why?
| Regression Analysis | 1 | 2005 | 256 |
Why?
| Quality Indicators, Health Care | 1 | 2003 | 34 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2003 | 14 |
Why?
| Vaginal Smears | 1 | 2003 | 31 |
Why?
| Clergy | 1 | 2002 | 5 |
Why?
| Fetus | 2 | 1993 | 105 |
Why?
| Karyotyping | 2 | 1978 | 47 |
Why?
| Meconium | 1 | 2002 | 7 |
Why?
| Suction | 1 | 2002 | 13 |
Why?
| Chi-Square Distribution | 1 | 2003 | 179 |
Why?
| Analysis of Variance | 2 | 2001 | 339 |
Why?
| Informed Consent | 1 | 2002 | 62 |
Why?
| Random Allocation | 1 | 2002 | 160 |
Why?
| Intubation, Intratracheal | 1 | 2002 | 50 |
Why?
| Cardiotocography | 1 | 2001 | 1 |
Why?
| Aged, 80 and over | 2 | 2002 | 599 |
Why?
| Cervix Uteri | 1 | 2001 | 38 |
Why?
| Progesterone Congeners | 1 | 2000 | 2 |
Why?
| Contraceptive Agents, Female | 1 | 2000 | 4 |
Why?
| Contraception | 1 | 2000 | 13 |
Why?
| Statistics, Nonparametric | 1 | 2001 | 141 |
Why?
| Utilization Review | 1 | 1999 | 16 |
Why?
| Trisomy | 1 | 1999 | 9 |
Why?
| Aged | 4 | 2002 | 988 |
Why?
| Minority Groups | 1 | 2000 | 38 |
Why?
| Benchmarking | 1 | 1999 | 28 |
Why?
| Reference Values | 1 | 2001 | 278 |
Why?
| Pain Measurement | 1 | 2001 | 98 |
Why?
| Adrenal Cortex | 1 | 1978 | 11 |
Why?
| Bucladesine | 1 | 1978 | 31 |
Why?
| Middle Aged | 4 | 2002 | 1161 |
Why?
| Heart Ventricles | 1 | 1999 | 86 |
Why?
| Herpesvirus 3, Human | 1 | 1998 | 14 |
Why?
| Urban Population | 2 | 1995 | 80 |
Why?
| Immunoglobulins | 1 | 1998 | 54 |
Why?
| Carrier State | 1 | 1998 | 20 |
Why?
| Pregnancy, High-Risk | 1 | 1997 | 12 |
Why?
| Clinical Protocols | 1 | 1998 | 93 |
Why?
| Treatment Outcome | 2 | 2002 | 661 |
Why?
| Hispanic Americans | 3 | 1995 | 57 |
Why?
| Rats | 2 | 1994 | 530 |
Why?
| Yohimbine | 1 | 1995 | 10 |
Why?
| Reserpine | 1 | 1995 | 8 |
Why?
| Infusions, Parenteral | 1 | 1996 | 38 |
Why?
| Tetrodotoxin | 1 | 1995 | 14 |
Why?
| Evidence-Based Medicine | 1 | 1997 | 125 |
Why?
| Drug Synergism | 1 | 1995 | 104 |
Why?
| Myocardial Contraction | 1 | 1995 | 52 |
Why?
| Hot Temperature | 1 | 1996 | 93 |
Why?
| Antibodies, Viral | 1 | 1998 | 104 |
Why?
| Genitalia | 1 | 1994 | 9 |
Why?
| Norepinephrine | 1 | 1995 | 68 |
Why?
| Sodium Channels | 1 | 1995 | 32 |
Why?
| Fetofetal Transfusion | 1 | 1994 | 5 |
Why?
| Hydrops Fetalis | 1 | 1994 | 10 |
Why?
| Aneuploidy | 1 | 1994 | 15 |
Why?
| Teratogens | 1 | 1994 | 17 |
Why?
| Chondrodysplasia Punctata | 1 | 1994 | 3 |
Why?
| Lethal Dose 50 | 1 | 1994 | 10 |
Why?
| Chromosomes | 1 | 1994 | 32 |
Why?
| Depression, Chemical | 1 | 1994 | 40 |
Why?
| Stimulation, Chemical | 1 | 1994 | 42 |
Why?
| Poverty | 1 | 1995 | 56 |
Why?
| Umbilical Arteries | 1 | 1993 | 12 |
Why?
| Drug Interactions | 1 | 1994 | 111 |
Why?
| Cell Line | 1 | 1978 | 375 |
Why?
| Statistics as Topic | 1 | 1994 | 133 |
Why?
| Ovarian Cysts | 1 | 1993 | 6 |
Why?
| Growth Disorders | 1 | 1993 | 26 |
Why?
| Hydronephrosis | 1 | 1993 | 22 |
Why?
| Intellectual Disability | 1 | 1993 | 51 |
Why?
| Medical Records | 2 | 2003 | 104 |
Why?
| European Continental Ancestry Group | 2 | 2000 | 117 |
Why?
| Neoplasm Staging | 2 | 2003 | 125 |
Why?
| Street Drugs | 1 | 1991 | 16 |
Why?
| Amniocentesis | 1 | 2010 | 17 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 2010 | 11 |
Why?
| Misoprostol | 1 | 2010 | 12 |
Why?
| Skin | 1 | 1993 | 177 |
Why?
| Disease Models, Animal | 1 | 1994 | 349 |
Why?
| False Positive Reactions | 1 | 2010 | 71 |
Why?
| Linear Models | 1 | 2010 | 151 |
Why?
| Follow-Up Studies | 1 | 1994 | 553 |
Why?
| Pregnancy Trimester, Third | 1 | 2008 | 28 |
Why?
| Colony Count, Microbial | 1 | 2007 | 45 |
Why?
| Animals | 2 | 1994 | 1031 |
Why?
| Asian Continental Ancestry Group | 1 | 2007 | 23 |
Why?
| African Continental Ancestry Group | 1 | 2007 | 80 |
Why?
| African Americans | 2 | 1995 | 108 |
Why?
| Iridium Radioisotopes | 1 | 2004 | 11 |
Why?
| Multivariate Analysis | 1 | 2007 | 225 |
Why?
| Radiopharmaceuticals | 1 | 2004 | 37 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2004 | 85 |
Why?
| Surgical Wound Dehiscence | 1 | 2003 | 19 |
Why?
| Disease-Free Survival | 1 | 2004 | 102 |
Why?
| Pelvis | 1 | 2003 | 38 |
Why?
| Catholicism | 1 | 2002 | 5 |
Why?
| Sarcoma | 1 | 2003 | 42 |
Why?
| Aorta, Thoracic | 1 | 2003 | 54 |
Why?
| Urinary Incontinence, Stress | 1 | 2002 | 7 |
Why?
| Postmenopause | 1 | 2002 | 27 |
Why?
| Lymphatic Metastasis | 1 | 2003 | 77 |
Why?
| Age Distribution | 1 | 2002 | 127 |
Why?
| Health Surveys | 1 | 2002 | 103 |
Why?
| Incidence | 1 | 2003 | 336 |
Why?
| Gravidity | 1 | 2000 | 6 |
Why?
| Menstruation Disturbances | 1 | 2000 | 9 |
Why?
| Weight Gain | 1 | 2000 | 30 |
Why?
| Receptors, Cyclic AMP | 1 | 1978 | 1 |
Why?
| Educational Status | 1 | 2000 | 99 |
Why?
| Prognosis | 1 | 2002 | 388 |
Why?
| Adrenocorticotropic Hormone | 1 | 1978 | 31 |
Why?
| Proportional Hazards Models | 1 | 2000 | 123 |
Why?
| Clone Cells | 1 | 1978 | 92 |
Why?
| Drug Resistance | 1 | 1978 | 83 |
Why?
| Severity of Illness Index | 1 | 2002 | 358 |
Why?
| Steroids | 1 | 1978 | 38 |
Why?
| Phosphates | 1 | 1978 | 71 |
Why?
| Protein Kinases | 1 | 1978 | 64 |
Why?
| Survival Analysis | 1 | 2000 | 205 |
Why?
| Cyclic AMP | 1 | 1978 | 89 |
Why?
| Questionnaires | 1 | 2002 | 360 |
Why?
| Cohort Studies | 1 | 2000 | 332 |
Why?
| Cell Division | 1 | 1978 | 273 |
Why?
| Drug Implants | 1 | 1995 | 15 |
Why?
| Patient Dropouts | 1 | 1995 | 24 |
Why?
| Hematocrit | 1 | 1994 | 60 |
Why?
| Diastole | 1 | 1993 | 21 |
Why?
| Patient Compliance | 1 | 1995 | 113 |
Why?
| Socioeconomic Factors | 1 | 1995 | 144 |
Why?
| Placenta | 1 | 1994 | 48 |
Why?
| Regional Blood Flow | 1 | 1993 | 105 |
Why?
| Mutation | 1 | 1978 | 340 |
Why?
| United States | 1 | 2000 | 604 |
Why?
|
|
Glantz's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
